Product Snapshot: Foxo
Welcome to the next post in our series of Product Snapshots in the Australian healthtech sector.
Say hello to Foxo.
In one sentence, describe your product?
Foxo is a real-time communication platform in use across public and private health.
What industry problem / challenge are you tackling?
The lack of a wide-reaching collaborative platform locks communication and information in silos behind primitive health systems.
86% of mistakes in healthcare are due to poor administration process and communication tools which leads to a cost of $1.7 billion in malpractice claims and nearly 2000 lives in the USA.
What is unique about your product in your market?
Foxo presents national and global health with an interoperable, collaborative platform (desktop/mobile) that enables borderless communication between clinicians, nurses, teams, departments, and organisations.
With layered clinical tools and patient workflows, Foxo is the gold standard for real-time messaging in health.
What is the biggest risk to your company?
Cost and procurement is a driving factor across health. Enterprise organisations (public and private) must realise the commercial benefit of a purpose-built and compliant communication tool which is easy to deploy, drives organisational efficiencies, and creates new inbound business via new and lasting referral networks.
What does success look like for the company?
The North Star is seeing Foxo prevail as a ubiquitous tool across global health resulting in better patient outcomes and organisational efficiencies.
Why should a customer use Foxo? Facebook messenger, WhatsApp, and Microsoft Teams provide basic support for progressive health organisations looking to improve efficiencies, connect staff, and provide better care.
Out of the box, Foxo (as a compliant tool) can solve these issues whilst significantly enhancing clinical workflows and engagement within and beyond the organisation.
How do we find out about Foxo?
Sign up for our no-nonsense Doctology Download newsletter at the bottom of this page.